Company: TYRA
Filing Date: 2025-04-18
Form Type: DEFA14A
Source: 0001193125-25-085711
Chunk: 1

Company: Tyra Biosciences, Inc.
Filing Date: 2025-04-18
Form: DEFA14A
Chunk 1
---
 REVERSE FOR FULL AGENDA Meeting Materials: Notice of Meeting, Proxy Statement and Annual Report on Form 10-KImportant Notice Regarding the Availability of Proxy Materials for the Stockholders Meeting to be held on May 29, 2025 For Stockholders of record as of April 4, 2025 To order paper materials, use one of the following methods. Internet: www.investorelections.com/TYRA Call: 1-866-648-8133Email: paper@investorelections.com * If requesting material by e-mail,please send a blank e-mailwith the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mailrequesting material. Your control number Have the 12 digit control number located in the box above available when you access the website and follow the instructions. Copyright © 2025 BetaNXT, Inc. or its affiliates. All Rights Reserved

THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR ON PROPOSALS 1 AND 2 Tyra Biosciences, Inc. Annual Meeting of Stockholders PROPOSAL 1. To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified. 1.01 Todd Harris, Ph.D. 1.02 Adele M. Gulfo 1.03 S. Michael Rothenberg, M.D., Ph.D. 2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. 3. To transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment of the Annual Meeting.